X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3989) 3989
Book Review (1006) 1006
Publication (317) 317
Book Chapter (49) 49
Conference Proceeding (9) 9
Dissertation (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3478) 3478
humans (2714) 2714
calcineurin inhibitors (2062) 2062
male (1684) 1684
transplantation (1394) 1394
female (1316) 1316
animals (1165) 1165
calcineurin (1144) 1144
tacrolimus (1047) 1047
adult (946) 946
middle aged (940) 940
immunosuppressive agents - therapeutic use (886) 886
immunosuppressive agents - administration & dosage (814) 814
surgery (782) 782
cyclosporine (776) 776
immunosuppressive agents - adverse effects (662) 662
immunology (636) 636
kidney transplantation (628) 628
treatment outcome (598) 598
tacrolimus - administration & dosage (595) 595
immunosuppression (587) 587
pharmacology & pharmacy (562) 562
graft rejection - prevention & control (451) 451
kidneys (451) 451
aged (449) 449
rats (448) 448
mice (442) 442
tacrolimus - therapeutic use (433) 433
calcineurin - metabolism (423) 423
recipients (420) 420
cyclosporine-a (408) 408
time factors (408) 408
analysis (402) 402
calcineurin inhibitor (397) 397
mycophenolate-mofetil (387) 387
risk factors (378) 378
dermatology (372) 372
sirolimus (370) 370
immunosuppressive agents - pharmacology (352) 352
drug therapy, combination (350) 350
tacrolimus - adverse effects (350) 350
cyclosporine - administration & dosage (346) 346
immunosuppressive agents (345) 345
adolescent (339) 339
retrospective studies (328) 328
transplants & implants (328) 328
health aspects (323) 323
child (320) 320
tacrolimus - pharmacology (318) 318
immunotherapy (312) 312
cyclosporine - pharmacology (304) 304
organ transplant recipients (297) 297
mycophenolic acid - analogs & derivatives (295) 295
research (294) 294
cyclosporine - therapeutic use (290) 290
therapy (285) 285
urology & nephrology (284) 284
immunosuppressive agents - pharmacokinetics (266) 266
liver transplantation (264) 264
kidney-transplantation (261) 261
liver (259) 259
dose-response relationship, drug (257) 257
pharmacokinetics (255) 255
young adult (251) 251
atopic dermatitis (247) 247
efficacy (247) 247
expression (243) 243
follow-up studies (243) 243
administration, topical (241) 241
cell biology (239) 239
renal-transplantation (232) 232
care and treatment (228) 228
dermatitis, atopic - drug therapy (226) 226
graft rejection (225) 225
neurosciences (225) 225
proteins (225) 225
signal transduction (225) 225
corticosteroids (224) 224
calcineurin inhibitors - therapeutic use (223) 223
everolimus (223) 223
rapamycin (219) 219
sirolimus - therapeutic use (219) 219
cyclosporine - adverse effects (218) 218
tacrolimus - analogs & derivatives (218) 218
calcineurin inhibitors - administration & dosage (217) 217
kidney transplantation - adverse effects (216) 216
prospective studies (216) 216
drug administration schedule (210) 210
sirolimus - administration & dosage (209) 209
drug therapy (207) 207
dosage and administration (206) 206
graft survival - drug effects (206) 206
children (205) 205
medicine & public health (202) 202
activation (201) 201
mycophenolic acid - therapeutic use (197) 197
tacrolimus - pharmacokinetics (196) 196
biochemistry & molecular biology (190) 190
mycophenolate mofetil (190) 190
heart (189) 189
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3918) 3918
German (38) 38
Japanese (21) 21
Spanish (15) 15
French (14) 14
Chinese (5) 5
Polish (4) 4
Italian (3) 3
Hungarian (2) 2
Korean (2) 2
Norwegian (2) 2
Portuguese (2) 2
Russian (2) 2
Catalan (1) 1
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Index Medicus | Abridged Index Medicus | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 05/2013, Volume 17, Issue 5, pp. 636 - 647
The use of the mammal target of rapamycin ( mTOR ) inhibitors has been consolidated as the therapy of election for preventing graft rejection in kidney... 
mTOR | calcium | thrombosis | Platelets | rapamycin | Rapamycin | Calcium | Thrombosis | MAMMALIAN TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | OPERATED CA2+ ENTRY | COMPLEX | PROTEIN | PHOSPHORYLATION | RECIPIENTS | CALCINEURIN CONTROLS | CELL BIOLOGY | DIFFERENTIAL SENSITIVITY | EXPRESSION | Blood Platelets - pathology | Demography | TOR Serine-Threonine Kinases - metabolism | Calcium - metabolism | Humans | Middle Aged | Male | TOR Serine-Threonine Kinases - antagonists & inhibitors | Time Factors | Adult | Female | Platelet Aggregation - drug effects | Homeostasis - drug effects | Phosphorylation - drug effects | Blood Platelets - drug effects | Everolimus | Sirolimus - analogs & derivatives | Kidney Transplantation | Enzyme Activation - drug effects | Sirolimus - pharmacology | Protein Kinase Inhibitors - administration & dosage | Sirolimus - administration & dosage | Signal Transduction - drug effects | Aged | Protein Kinase Inhibitors - pharmacology | Homeostasis | Transplantation | Kidneys | Analysis | Yeast | Antibiotics | Transplants & implants | Blood platelets | TOR protein | Phosphorylation | Renal function | Sirolimus | Cyclosporins | Calcineurin | Leukocytes | Kinases | Immunosuppressive agents | Elections | Time dependence | Physiology | Calcium homeostasis | Thrombocytopenia | Streptomyces hygroscopicus | Secretion | Platelet aggregation | Graft rejection | Side effects | Inhibitors | Tacrolimus | Kidney transplantation | Index Medicus | Original
Journal Article
Transplantation, ISSN 0041-1337, 08/2016, Volume 100, Issue 8, pp. 1723 - 1731
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 08/2014, Volume 14, Issue 8, pp. 1828 - 1838
Journal Article
Transplantation, ISSN 0041-1337, 11/2017, Volume 101, Issue 11, pp. 2793 - 2800
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 11/2016, Volume 16, Issue 11, pp. 3255 - 3261
Long‐term renal transplant outcome is limited by side effects of immunosuppressive drugs, particularly calcineurin inhibitor ( CNI ). We assumed that some... 
clinical trial | chronic allograft nephropathy | immunosuppression/immune modulation | clinical research/practice | kidney transplantation/nephrology | alloantibody | biopsy | immunosuppressant | SURGERY | IMMUNOSUPPRESSION | FOLLOW-UP | RISK | RENAL-TRANSPLANTATION | OUTCOMES | OPERATIONAL TOLERANCE | PEDIATRIC LIVER | WITHDRAWAL | MYCOPHENOLATE-MOFETIL | CYCLOSPORINE | TRANSPLANTATION | Prospective Studies | Follow-Up Studies | Weaning | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Transplant Recipients | Kidney Function Tests | Young Adult | Treatment Failure | Aged, 80 and over | Adult | Female | Postoperative Complications - drug therapy | Tacrolimus - administration & dosage | Graft Rejection - drug therapy | Glomerular Filtration Rate | Kidney Failure, Chronic - surgery | Double-Blind Method | Calcineurin Inhibitors - administration & dosage | Graft Rejection - etiology | Adolescent | Aged | Graft Survival - drug effects | Kidney Transplantation - adverse effects | Viral antibodies | Kidneys | Tacrolimus | Analysis | Clinical trials | Antibodies | Organ transplant recipients | Transplantation | Kidney diseases | Transplants & implants | Immunology | Immunization | Renal function | Calcineurin | Immunosuppressive agents | Graft rejection | Side effects | Allografts | Histocompatibility antigen HLA | Kidney transplantation | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Journal Article
International Journal of Urology, ISSN 0919-8172, 02/2018, Volume 25, Issue 2, pp. 141 - 145
ObjectiveTo evaluate the utility and safety of high-dose mizoribine combination therapy using cyclosporine and tacrolimus as calcineurin inhibitors in patients... 
combination therapy | cytomegalovirus | renal transplantation | mizoribine | calcineurin inhibitors | UROLOGY & NEPHROLOGY | RECIPIENTS | MYCOPHENOLATE-MOFETIL | Kidney Failure, Chronic - mortality | Glucocorticoids - administration & dosage | Graft Survival - immunology | Humans | Middle Aged | Male | Drug Therapy, Combination - adverse effects | Graft Rejection - epidemiology | Ribonucleosides - administration & dosage | Adult | Female | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Kidney Failure, Chronic - surgery | Calcineurin Inhibitors - administration & dosage | Graft Rejection - prevention & control | Basiliximab - adverse effects | Survival Rate | Treatment Outcome | Tacrolimus - adverse effects | Calcineurin Inhibitors - adverse effects | Drug Therapy, Combination - methods | Basiliximab - administration & dosage | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Ribonucleosides - adverse effects | Graft Rejection - immunology | Graft Survival - drug effects | Kidney Transplantation - adverse effects | Medical research | Corticosteroids | Kidneys | Tacrolimus | Immunotherapy | Medicine, Experimental | Cytomegalovirus infections | Dosage and administration | Transplantation | Cyclosporine | Corticoids | Renal function | Transplants & implants | Cyclosporins | Calcineurin | Calcineurin inhibitors | ABO system | Patients | Survival | Graft rejection | Immunosuppression | Blood groups | Kidney transplantation | Index Medicus
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 06/2011, Volume 6, Issue 6, pp. 1308 - 1315
Journal Article
Journal Article
13.